Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Catalogo dei prodotti della ricerca
Background and aims: Contemporary multicentre data on clinical and diagnostic spectrum and outcome in myocarditis are limited. Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven myocarditis (2013 European Society of Cardiology criteria) in adult and paediatric patients from the EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry. Methods: Five hundred eighty-one (68.0% male) patients, 493 adults, median age 38 (27-52) years, and 88 children, aged 8 (3-13) years, were divided into 3 groups: Group 1 (n = 233), clinically suspected myocarditis with abnormal cardiac magnetic resonance; Group 2 (n = 222), biopsy-proven myocarditis; and Group 3 (n = 126) clinically suspected myocarditis with normal or inconclusive or no cardiac magnetic resonance. Baseline features were analysed overall, in adults vs. children, and among groups. One-year outcome events included death/heart transplantation, ventricular assist device (VAD) or implantable cardioverter defibrillator (ICD) implantation, and hospitalization for cardiac causes. Results: Endomyocardial biopsy, mainly right ventricular, had a similarly low complication rate in children and adults (4.7% vs. 4.9%, P = NS), with no procedure-related death. A classical myocarditis pattern on cardiac magnetic resonance was found in 31.3% of children and in 57.9% of adults with biopsy-proven myocarditis (P < .001). At 1-year follow-up, 11/410 patients (2.7%) died, 7 (1.7%) received a heart transplant, 3 underwent VAD (0.7%), and 16 (3.9%) underwent ICD implantation. Independent predictors at diagnosis of death or heart transplantation or hospitalization or VAD implantation or ICD implantation at 1-year follow-up were lower left ventricular ejection fraction and the need for immunosuppressants for new myocarditis diagnosis refractory to non-aetiology-driven therapy. Conclusions: Endomyocardial biopsy was safe, and cardiac magnetic resonance using Lake Louise criteria was less sensitive, particularly in children. Virus-negative lymphocytic myocarditis was predominant both in children and adults, and use of immunosuppressive treatments was low. Lower left ventricular ejection fraction and the need for immunosuppressants at diagnosis were independent predictors of unfavourable outcome events at 1 year.
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry / Caforio, Alida L P; Kaski, Juan P; Gimeno, Juan R; Elliott, Perry M; Laroche, Cecile; Tavazzi, Luigi; Tendera, Michal; Fu, Michael; Sala, Simone; Seferovic, Petar M; Heliö, Tiina; Calò, Leonardo; Blagova, Olga; Amin, Ahmad; Kindermann, Ingrid; Sinagra, Gianfranco; Frustaci, Andrea; Bonnet, Daniel; Charron, Philippe; Maggioni, Aldo P; Null, Null; Ferrari, R; Alonso, A; Bax, J; Blomström-Lundqvist, C; Gielen, S; Lancellotti, P; Maggioni, A P; Maniadakis, N; Pinto, F; Ruschitzka, F; Tavazzi, L; Vardas, P; Weidinger, F; Zeymer, U; Vahanian, A; Budaj, A; Dagres, N; Danchin, N; Delgado, V; Emberson, J; Friberg, O; Gale, C P; Heyndrickx, G; Iung, B; James, S; Kappetein, A P; Maggioni, A P; Maniadakis, N; Nagy, K V; Parati, G; Petronio, A-S; Pietila, M; Prescott, E; Ruschitzka, F; Van de Werf, F; Weidinger, F; Zeymer, U; Gale, C P; Beleslin, B; Budaj, A; Chioncel, O; Dagres, N; Danchin, N; Emberson, J; Erlinge, D; Glikson, M; Gray, A; Kayikcioglu, M; Maggioni, A P; Nagy, K V; Nedoshivin, A; Petronio, A-P; Roos-Hesselink, J W; Wallentin, L; Zeymer, U; Popescu, B A; Adlam, D; Caforio, A L P; Capodanno, D; Dweck, M; Erlinge, D; Glikson, M; Hausleiter, J; Iung, B; Kayikcioglu, M; Ludman, P; Lund, L; Maggioni, A P; Matskeplishvili, S; Meder, B; Nagy, K V; Nedoshivin, A; Neglia, D; Pasquet, A A; Roos-Hesselink, J W; Rossello, F J; Shaheen, S M; Torbica, A; Caforio, Alida; Gimeno Blanes, Juan Ramon; Charron, Philippe; Elliott, Perry; Kaski, Juan Pablo; Maggioni, Aldo P; Tavazzi, Luigi; Tendera, Michal; Pihkala, J; Ojala, T; Hiippala, A; Jarvinen, T; Lommi, J; Helio, T; Sinisalo, J; Bonnet, D; Khraiche, D; Szezepanski, I; Charron, P; Mankikian, S; Maupain, C; Collet, J-P; Gandjbakhch, E; Kerneis, M; Pruny, J-F; Bauer, A; Pfeiffer, B; Felix, S B; Beug, D; Dorr, M; Kaczmarek, S; Lehnert, K; Pedersen, A-L; Bruder, M; Gorenflo, M; Arnold, R; Uhl, S; Ziesenitz, V; Jung, A; Roesch, E; Böhm, M; Kindermann, I; Linicus, Y; Werner, C; Neurath, B; Schild-Ungerbuehler, M; Kindermann, M; Kaski, J P; Norrish, G; Field, E; Elliott, P; Lorenzini, M; Watkinson, O; Wicks, E; Anastasakis, A; Ritsatos, K; Vlagkouli, V; Rammos, S; Kourelis, G; Giannakopoulou, A; Karanasios, E; Papachristou, P; Papadopoulos, G; Servos, G; Maleki, M; Noohi Bezanjani, F; Amin, A; Naderi, N; Parsaee, M; Taghavi, S; Ghadrdoost, B; Jafari, S; Khoshavi, M; Della Bella, P; Sala, S; Peretto, G; Calabro, R; Pacileo, G; Russo, M G; Limongelli, G; Esposito, A; Gragnano, F; Gravino, R; Marrazzo, T; Masarone, D; Pazzanese, V; Rubino, M; Tramonte, S; Valente, F; Caiazza, M; Calabro, P; Cirillo, A; Trimarco, B; Losi, M-A; Di Nardo, C; Giamundo, A; Pacelli, F; Canciello, G; Iliceto, S; Caforio, A; Calore, C; Leoni, L; Perazzolo Marra, M; Rigato, I; Tarantini, G; Schiavo, A; Testolina, M; Fedele, F; Frustaci, A; Alfarano, M; Chimenti, C; Drago, F; Baban, A; Calò, L; Lanzillo, C; Martino, A; Uguccioni, M; Zachara, E; Halasz, G; Re, F; Sinagra, G; Carriere, C; Merlo, M; Ramani, F; Kavoliuniene, A; Krivickiene, A; Tamuleviciute-Prasciene, E; Viezelis, M; Celutkiene, J; Balkeviciene, L; Laukyte, M; Paleviciute, E; Asselbergs, F; De Jonge, N; Kirkels, J H; Van Der Heijden, J; Van Laake, L; Sammani, A; Mizia-Stec, K; Tendera, M; Wybraniec, M; Czekaj, A; Sikora-Puz, A; Skoczynska, A; Rubis, P; Wisniowska-Smialek, S; Grzybowski, J; Ojrzynska, N; Bilinska, Z; Chmielewski, P; Foss-Nieradko, B; Michalak, E; Stepien-Wojno, M; Mazek, B; Brzezinska-Rajszys, G; Ziolkowska, L; Boruc, A; Plodzien, E; Rocha Lopes, L; Almeida, A R; Cruz, I; Gomes, A C; Pereira, A R; Ginghina, C; Jurcut, R; Apetrei, E; Militaru, S; Mircea Coman, I; Mursa, A; Popescu, B A; Frigy, A; Fehervari, L; Fogarasi, Z; Kocsis, I; Szabo, I A; Nikitin, I; Resnik, E; Komissarova, M; Lazarev, V; Shebzukhova, M; Ustyuzhanin, D; Blagova, O; Alieva, I; Kulikova, V; Lutokhina, Y; Pavlenko, E; Varionchik, N; Zaklyazminskaya, E; Dzemeshkevich, S; Kolbasova, E; Kotlukova, N; Rusinova, V; Ristic, A D; Seferovic, P M; Pavlovic, A; Radovanovic, G; Simeunovic, D; Zivkovic, I; Milinkovic, I; Gran Ipina, F; Roses Noguer, F; Albert Brotons, D; Cequier, A; Salazar-Mendiguchia, J; Gonzalez, J; Manito, N; Garcia-Pavia, P; Briceno, A; Cobo-Marcos, M; Dominguez, F; Gimeno Blanes, J R; Castro, F J; Munoz Esparza, C; Sabater Molina, M; Sorli García, M; Lopez Cuenca, D; Ripoll-Vera, T; Alvarez, J; Nunez, J; Gomez, Y; Sanchez Fernandez, P L; Villacorta, E; Avila, C; Bravo, L; Diaz-Pelaez, E; Gallego-Delgado, M; Garcia-Cuenllas, L; Plata, B; Fu, M; Canpolat, U. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - 45:28(2024), pp. 2548-2569. [10.1093/eurheartj/ehae169]
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry
Background and aims: Contemporary multicentre data on clinical and diagnostic spectrum and outcome in myocarditis are limited. Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven myocarditis (2013 European Society of Cardiology criteria) in adult and paediatric patients from the EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry. Methods: Five hundred eighty-one (68.0% male) patients, 493 adults, median age 38 (27-52) years, and 88 children, aged 8 (3-13) years, were divided into 3 groups: Group 1 (n = 233), clinically suspected myocarditis with abnormal cardiac magnetic resonance; Group 2 (n = 222), biopsy-proven myocarditis; and Group 3 (n = 126) clinically suspected myocarditis with normal or inconclusive or no cardiac magnetic resonance. Baseline features were analysed overall, in adults vs. children, and among groups. One-year outcome events included death/heart transplantation, ventricular assist device (VAD) or implantable cardioverter defibrillator (ICD) implantation, and hospitalization for cardiac causes. Results: Endomyocardial biopsy, mainly right ventricular, had a similarly low complication rate in children and adults (4.7% vs. 4.9%, P = NS), with no procedure-related death. A classical myocarditis pattern on cardiac magnetic resonance was found in 31.3% of children and in 57.9% of adults with biopsy-proven myocarditis (P < .001). At 1-year follow-up, 11/410 patients (2.7%) died, 7 (1.7%) received a heart transplant, 3 underwent VAD (0.7%), and 16 (3.9%) underwent ICD implantation. Independent predictors at diagnosis of death or heart transplantation or hospitalization or VAD implantation or ICD implantation at 1-year follow-up were lower left ventricular ejection fraction and the need for immunosuppressants for new myocarditis diagnosis refractory to non-aetiology-driven therapy. Conclusions: Endomyocardial biopsy was safe, and cardiac magnetic resonance using Lake Louise criteria was less sensitive, particularly in children. Virus-negative lymphocytic myocarditis was predominant both in children and adults, and use of immunosuppressive treatments was low. Lower left ventricular ejection fraction and the need for immunosuppressants at diagnosis were independent predictors of unfavourable outcome events at 1 year.
01 Pubblicazione su rivista::01a Articolo in rivista
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry / Caforio, Alida L P; Kaski, Juan P; Gimeno, Juan R; Elliott, Perry M; Laroche, Cecile; Tavazzi, Luigi; Tendera, Michal; Fu, Michael; Sala, Simone; Seferovic, Petar M; Heliö, Tiina; Calò, Leonardo; Blagova, Olga; Amin, Ahmad; Kindermann, Ingrid; Sinagra, Gianfranco; Frustaci, Andrea; Bonnet, Daniel; Charron, Philippe; Maggioni, Aldo P; Null, Null; Ferrari, R; Alonso, A; Bax, J; Blomström-Lundqvist, C; Gielen, S; Lancellotti, P; Maggioni, A P; Maniadakis, N; Pinto, F; Ruschitzka, F; Tavazzi, L; Vardas, P; Weidinger, F; Zeymer, U; Vahanian, A; Budaj, A; Dagres, N; Danchin, N; Delgado, V; Emberson, J; Friberg, O; Gale, C P; Heyndrickx, G; Iung, B; James, S; Kappetein, A P; Maggioni, A P; Maniadakis, N; Nagy, K V; Parati, G; Petronio, A-S; Pietila, M; Prescott, E; Ruschitzka, F; Van de Werf, F; Weidinger, F; Zeymer, U; Gale, C P; Beleslin, B; Budaj, A; Chioncel, O; Dagres, N; Danchin, N; Emberson, J; Erlinge, D; Glikson, M; Gray, A; Kayikcioglu, M; Maggioni, A P; Nagy, K V; Nedoshivin, A; Petronio, A-P; Roos-Hesselink, J W; Wallentin, L; Zeymer, U; Popescu, B A; Adlam, D; Caforio, A L P; Capodanno, D; Dweck, M; Erlinge, D; Glikson, M; Hausleiter, J; Iung, B; Kayikcioglu, M; Ludman, P; Lund, L; Maggioni, A P; Matskeplishvili, S; Meder, B; Nagy, K V; Nedoshivin, A; Neglia, D; Pasquet, A A; Roos-Hesselink, J W; Rossello, F J; Shaheen, S M; Torbica, A; Caforio, Alida; Gimeno Blanes, Juan Ramon; Charron, Philippe; Elliott, Perry; Kaski, Juan Pablo; Maggioni, Aldo P; Tavazzi, Luigi; Tendera, Michal; Pihkala, J; Ojala, T; Hiippala, A; Jarvinen, T; Lommi, J; Helio, T; Sinisalo, J; Bonnet, D; Khraiche, D; Szezepanski, I; Charron, P; Mankikian, S; Maupain, C; Collet, J-P; Gandjbakhch, E; Kerneis, M; Pruny, J-F; Bauer, A; Pfeiffer, B; Felix, S B; Beug, D; Dorr, M; Kaczmarek, S; Lehnert, K; Pedersen, A-L; Bruder, M; Gorenflo, M; Arnold, R; Uhl, S; Ziesenitz, V; Jung, A; Roesch, E; Böhm, M; Kindermann, I; Linicus, Y; Werner, C; Neurath, B; Schild-Ungerbuehler, M; Kindermann, M; Kaski, J P; Norrish, G; Field, E; Elliott, P; Lorenzini, M; Watkinson, O; Wicks, E; Anastasakis, A; Ritsatos, K; Vlagkouli, V; Rammos, S; Kourelis, G; Giannakopoulou, A; Karanasios, E; Papachristou, P; Papadopoulos, G; Servos, G; Maleki, M; Noohi Bezanjani, F; Amin, A; Naderi, N; Parsaee, M; Taghavi, S; Ghadrdoost, B; Jafari, S; Khoshavi, M; Della Bella, P; Sala, S; Peretto, G; Calabro, R; Pacileo, G; Russo, M G; Limongelli, G; Esposito, A; Gragnano, F; Gravino, R; Marrazzo, T; Masarone, D; Pazzanese, V; Rubino, M; Tramonte, S; Valente, F; Caiazza, M; Calabro, P; Cirillo, A; Trimarco, B; Losi, M-A; Di Nardo, C; Giamundo, A; Pacelli, F; Canciello, G; Iliceto, S; Caforio, A; Calore, C; Leoni, L; Perazzolo Marra, M; Rigato, I; Tarantini, G; Schiavo, A; Testolina, M; Fedele, F; Frustaci, A; Alfarano, M; Chimenti, C; Drago, F; Baban, A; Calò, L; Lanzillo, C; Martino, A; Uguccioni, M; Zachara, E; Halasz, G; Re, F; Sinagra, G; Carriere, C; Merlo, M; Ramani, F; Kavoliuniene, A; Krivickiene, A; Tamuleviciute-Prasciene, E; Viezelis, M; Celutkiene, J; Balkeviciene, L; Laukyte, M; Paleviciute, E; Asselbergs, F; De Jonge, N; Kirkels, J H; Van Der Heijden, J; Van Laake, L; Sammani, A; Mizia-Stec, K; Tendera, M; Wybraniec, M; Czekaj, A; Sikora-Puz, A; Skoczynska, A; Rubis, P; Wisniowska-Smialek, S; Grzybowski, J; Ojrzynska, N; Bilinska, Z; Chmielewski, P; Foss-Nieradko, B; Michalak, E; Stepien-Wojno, M; Mazek, B; Brzezinska-Rajszys, G; Ziolkowska, L; Boruc, A; Plodzien, E; Rocha Lopes, L; Almeida, A R; Cruz, I; Gomes, A C; Pereira, A R; Ginghina, C; Jurcut, R; Apetrei, E; Militaru, S; Mircea Coman, I; Mursa, A; Popescu, B A; Frigy, A; Fehervari, L; Fogarasi, Z; Kocsis, I; Szabo, I A; Nikitin, I; Resnik, E; Komissarova, M; Lazarev, V; Shebzukhova, M; Ustyuzhanin, D; Blagova, O; Alieva, I; Kulikova, V; Lutokhina, Y; Pavlenko, E; Varionchik, N; Zaklyazminskaya, E; Dzemeshkevich, S; Kolbasova, E; Kotlukova, N; Rusinova, V; Ristic, A D; Seferovic, P M; Pavlovic, A; Radovanovic, G; Simeunovic, D; Zivkovic, I; Milinkovic, I; Gran Ipina, F; Roses Noguer, F; Albert Brotons, D; Cequier, A; Salazar-Mendiguchia, J; Gonzalez, J; Manito, N; Garcia-Pavia, P; Briceno, A; Cobo-Marcos, M; Dominguez, F; Gimeno Blanes, J R; Castro, F J; Munoz Esparza, C; Sabater Molina, M; Sorli García, M; Lopez Cuenca, D; Ripoll-Vera, T; Alvarez, J; Nunez, J; Gomez, Y; Sanchez Fernandez, P L; Villacorta, E; Avila, C; Bravo, L; Diaz-Pelaez, E; Gallego-Delgado, M; Garcia-Cuenllas, L; Plata, B; Fu, M; Canpolat, U. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - 45:28(2024), pp. 2548-2569. [10.1093/eurheartj/ehae169]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1727524
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
ND
3
3
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.